drugset / Trial / NCT04428372
MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)
RandomizedCrossoverQuadruple-blindPrevention
Summary
This proposal will measure the effects of mannitol administration versus placebo in hypotensive-prone, adult, maintenance hemodialysis patients with respect to changes in patient symptoms and blood pressure stability.
Timeline
- Start
- 2021-04-06
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mannitol | Diagnostic / imaging agent | 0.25 g/kg | Intravenous |
Indications
No indication recorded.